Asset Dedication’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.7K Hold
167
– – ﹤0.01% 798
2026
Q2
$10.8K Hold
167
– – ﹤0.01% 774
2026
Q1
$8.74K Hold
167
– – ﹤0.01% 784
2025
Q4
$8.55K Hold
167
– – ﹤0.01% 811
2025
Q3
$6.49K Hold
167
– – ﹤0.01% 874
2025
Q2
$5.02K Hold
167
– – ﹤0.01% 920
2025
Q1
$4.76K Hold
167
– – ﹤0.01% 861
2024
Q4
$5.52K Hold
167
– – ﹤0.01% 844
2024
Q3
$6.24K Hold
167
– – ﹤0.01% 869
2024
Q2
$5.61K Hold
167
– – ﹤0.01% 904
2024
Q1
$6K Hold
167
– – ﹤0.01% 759
2023
Q4
$6K Hold
167
– – ﹤0.01% 776
2023
Q3
$5K Hold
167
– – ﹤0.01% 795
2023
Q2
$5K Hold
167
– – ﹤0.01% 781
2023
Q1
$5K Hold
167
– – ﹤0.01% 761
2022
Q4
$5K Hold
167
– – ﹤0.01% 768
2022
Q3
$5K Hold
167
– – ﹤0.01% 720
2022
Q2
$5K Hold
167
– – ﹤0.01% 401
2022
Q1
$6K Hold
167
– – ﹤0.01% 729
2021
Q4
$7K Hold
167
– – ﹤0.01% 697
2021
Q3
$8K Hold
167
– – ﹤0.01% 735
2021
Q2
$8K Buy
+167
New +$8K ﹤0.01% 669

Other funds holding SBIO

Asset Dedication's SBIO Position: Q3 2026 in Review

Asset Dedication held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q3 2026 at 167 shares worth $9.7K. The position accounts for ﹤0.01% of the portfolio, ranked #798.

Asset Dedication first reported a position in SBIO in Q2 2021 and has held it in 22 quarters since. The position peaked at $10.8K in Q2 2026. 60 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

  • Asset Dedication held 167 shares of ALPS Medical Breakthroughs ETF worth $9.7K as of Q3 2026.
  • Asset Dedication left its ALPS Medical Breakthroughs ETF share count unchanged in Q3 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #798 holding.
  • Asset Dedication first reported a position in ALPS Medical Breakthroughs ETF in Q2 2021 and has held it in 22 quarters since.
  • Asset Dedication's ALPS Medical Breakthroughs ETF position peaked at $10.8K in Q2 2026.
  • 60 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.